Search Within

Heiko Schoder

  1. "Michael Morris"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (10)
  3. Book Section (1)
Groups
  1. Department of Medicine (25)
  2. Genitourinary Oncology Service (25)
  3. Molecular Imaging and Therapy Service (25)
  4. Radiology, Department of (25)
  5. Solid Tumor Oncology Division (25)
  6. GSK Faculty (18)

More Groups

People
  1. Michael Morris (25)
  2. Howard Scher (18)
  3. Steven Larson (16)
  4. Josef Fox (15)
  5. John Humm (11)
  6. Karen Autio (7)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (1)
  5. 2021 (2)
  6. 2020 (1)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Journal of Nuclear Medicine (3)
  3. Acta Oncologica (1)
  4. Annals of Oncology (1)
  5. Cancer Research (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Society of Nuclear Medicine (3)
  3. American Association for Cancer Research (2)
  4. Springer (2)
  5. American Medical Association (1)
  6. Elsevier BV (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical, imaging, and technical factors associated with successful genomic profiling of bone biopsy tissue in prostate cancer
    Journal Article

    Ridouani, F.; Vargas, H. A.; Holzwanger, D. J.; Schöder, H.; Waters, E.; Petre, E. N.; Martin, A.; Satagopan, J.; Gonen, M.; Autio, K. A.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Prostate cancer working group 4 (PCWG4) preliminary criteria using serial PSMA PET/CT for response evaluation: Analysis from the PRINCE trial
    Meeting Abstract

    Hofman, M. S.; Gafita, A.; Bressel, M.; Alipour, R.; Levy, S.; Emmett, L.; Ravi Kumar, A. S.; Hamid, A. A.; Buteau, J. P.; Kuo, P. H.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • A pilot study of stereotactic body radiotherapy and (177)Lu-PSMA-617 for oligometastatic hormone sensitive prostate cancer
    Meeting Abstract

    Imber, B. S.; Bodei, L.; Humm, J.; Ionescu, A.; Wu, W.; Grkovski, M.; O'Donoghue, J.; Reddy, R. P.; Rimner, A.; Shasha, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT
    Journal Article

    McLaughlin, L. A.; Yildirim, O.; Rosenblum, M. K.; Imber, B. S.; Haseltine, J. M.; Zelefsky, M. J.; Schöder, H.; Morris, M. J.; Rafelson, W. M.; Krebs, S.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Advances in prostate cancer imaging
    Book Section

    Razmaria, A. A.; Schoder, H.; Morris, M. J.
    In Stratton, K. L.; Morgans, A. K. (Eds.) Urologic Oncology: Multidisciplinary Care for Patients (2022)

    Fulltext@MSK | Save
  • Bcl-2 inhibitor enhances anti-androgen therapy induced regression of castration sensitive prostate cancer
    Meeting Abstract

    Hirani, R.; Nandakumar, S.; Kalidindi, T.; Fidele, D.; Rajanala, H.; Mazzu, Y.; Yoshikawa, Y.; Jehane, L.; Lee, G. S. M.; de Stanchina, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Nandakumar, S.; Kalidindi, T. M.; Fidele, D.; Rajanala, S. H.; Mazzu, Y. Z.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • (11)C-choline PET/CT in recurrent prostate cancer: Retrospective analysis in a large U.S. patient series
    Journal Article

    Michaud, L.; Touijer, K. A.; Mauguen, A.; Zelefsky, M. J.; Morris, M. J.; Lyashschenko, S. K.; Durack, J. C.; Humm, J. L.; Weber, W. A.; Schöder, H.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Positron emission tomography/computed tomography-based assessments of androgen receptor expression and glycolytic activity as a prognostic biomarker for metastatic castration-resistant prostate cancer
    Journal Article

    Fox, J. J.; Gavane, S. C.; Blanc-Autran, E.; Nehmeh, S.; Gonen, M.; Beattie, B.; Vargas, H. A.; Schoder, H.; Humm, J. L.; Fine, S. W.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save